Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KTP-001 in Lumbar Disc Herniation
NCT01978912Phase 2Completed
- Sponsor
- Teijin
- Start
- Feb 2013
- Primary completion
- Oct 2018
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human matrix metalloproteinase in lumbar disc herniation (LDH), sponsored by Teijin. Started Feb 2013; status: completed.
02
Drugs
recombinant human matrix metalloproteinase
03
Conditions
lumbar disc herniation (LDH)
Beyond the preview
Go deeper on NCT01978912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01978912.